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Non-invasive and cost effective in nature, the echocardiogram allows for a comprehensive assessment of the cardiac 
musculature and valves. Despite progressive improvements over the decades, the rich temporally resolved data in 
echocardiography videos remain underutilized. Human reads of echocardiograms reduce the complex patterns of 
cardiac wall motion, to a small list of measurements of heart function. Furthermore, all modern echocardiography 
artificial intelligence (AI) systems are similarly limited by design – automating measurements of the same 
reductionist metrics rather than utilizing the wealth of data embedded within each echo study. This underutilization 
is most evident in situations where clinical decision making is guided by subjective assessments of disease acuity, 
and tools that predict disease onset within clinically actionable timeframes are unavailable.1 Predicting the likelihood 
of developing post-operative right ventricular failure (RV failure) in the setting of mechanical circulatory support is 
one such clinical example.2,3 To address this, we developed a novel video AI system trained to predict post-operative 
right ventricular failure (RV failure), using the full spatiotemporal density of information from pre-operative 
echocardiography scans. We achieve an AUC of 0.729, specificity of 52% at 80% sensitivity and 46% sensitivity at 
80% specificity. Furthermore, we show that our ML system significantly outperforms a team of human experts tasked 
with predicting RV failure on independent clinical evaluation. Finally, the methods we describe are generalizable to 





Predicting which patients will go on to develop RV failure after implantation of a left ventricular assist device has so 
far remained beyond the abilities of both human experts and existing automated algorithms. A variety of clinical 
scoring systems have been developed with modest predictive power, with a maximum area under the receiver 
operating characteristic curve (AUC) of 0.60 in held-out datasets.1,4–7 Without reliable methods to predict RV failure 
in the pre-operative setting, we have neither the means to decide in whom to aggressively intervene, nor an efficient 
method to randomize patients to trials that evaluate the efficacy of right ventricular treatment options. The gold 
standard method for determining which patients should receive advanced right ventricular support devices thus 
remains a ‘clinical gestalt’,8 involving the patients’ clinical course, lab parameters, and a qualitative assessment of 
myocardial function using a transthoracic echocardiogram. In this study, we describe a novel echocardiography 
machine learning system that enables time resolved characterization of motion parameters from each scan. We use 
this ML system to predict post-operative RV failure in LVAD patients, using pre-operative echocardiograms alone. 
We compare the predictions of our ML system to those of contemporary RV failure risk scores, and further show 
that our ML system outperforms heart failure echocardiography experts in independent clinical evaluation.  Figure 
1 details an overview of the project.  
 
In recent years, artificial intelligence has enabled automated systems to meet or exceed the performance of clinical 
experts across a range of image analysis tasks, from detection and diagnosis of disease to prediction of disease 
progression.9–13  These systems typically draw conclusions from static images. Our video AI system processes two 
parallel spatiotemporal streams of data from echocardiography videos. The greyscale video channel and optical flow 
streams are combined within the convolutional neural network architecture with concatenation of activations prior 
to the terminal fully connected layers. We tested a variety of approaches, including various pretraining strategies, 
optimizers, input streams, and model architectures. Ultimately, we selected a 3-dimensional 152-layer residual 
network for our echocardiography ML system as it gave the best performance. Architectural details and training 
strategy are detailed in the methods section. The area under curve (AUC) of the receiver operating characteristic 
(ROC) curve of our AI system, on the holdout testing dataset is shown in Fig 2a. The ROC AUC for the AI system was 
0.729 (95% CI 0.623-0.835; n = 121 patients; 327 scans). The corresponding Precision-Recall curves are shown in 
Supplementary Fig 4.  
 
Multi-center clinical and echocardiographic RV failure dataset 
 
Heart failure affects more than 6.5 million people in the United States alone, with an estimated 960,000 new cases 
diagnosed each year.14 A heart transplant remains the gold standard for treating patients with end-stage heart 
failure. Demand, however, far outpaces the supply of transplantable hearts.15,16  Left ventricular assist devices 
(LVADs) offer a mechanical alternative to transplantation, and the number of patients supported by these battery 
powered mechanical pumps have steadily grown.17 In the contemporary era, an estimated 3500 LVAD implants are 
performed each year, approximately equal to the number of annual heart transplants in the United States.2,18 
Unfortunately, a third of all patients implanted with LVADs, develop a clinically significant degree of right ventricular 
failure (RV failure) soon after the procedure.4,19 Underlying RV dysfunction and physiological changes under LVAD 
flow are both thought to contribute to the development of severe post-operative RV failure, which remains the 
single largest contributor to short-term mortality in this patient population.2,3,20,21  
 
A dataset containing pre-operative and post-operative clinical variables along with paired transthoracic 
echocardiography studies was collected from three hospitals in the United States. The dataset consisted of 941 
consecutive patients who had LVAD implants. 44 records were discarded due to missing data on duration of post-
operative inotropes that prevented the adjudication of RV failure status. Data from an additional 173 patients were 
discarded because of missing apical 4-chamber echocardiograms or insufficient number of frames per video 
(Supplementary Fig. 3 and Supplementary Table 5). The dataset consisted of 159 (21.9%) females, and 562 (77.6%) 
male patients with an average age of 57.4 (sd 13.1) years. These figures are representative of the general LVAD 
patient population, and additional baseline characteristics and demographics by data split are outlined in 
Supplementary Table 3.22,23 Most pre-operative scans were acquired at a median of 9 days (IQR 13 days) prior to 
LVAD implant. Patients undergoing surgery for a LVAD implant typically recover in the setting of a cardiac intensive 
care unit, where hemodynamic parameters (via invasive catheters) and clinical course determines the diagnosis of 
post-operative RV failure. We used the latest MCS ARC (Mechanical Circulatory Support Academic Research 
Consortium) consensus definitions to grade each patient for post-operative RV failure to provide accurate and 
standardized clinical ground truth labels (Supplementary Table 1).24  Briefly, this incorporates invasive hemodynamic 
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Fig. 1a Pre-operative echocardiography videos are processed as a stack of 32 frames. A two-stream implementation of raw 
greyscale videos and optical flow channels are fed into a 3D convolutional neural network to produce the prediction of RV failure. 
b. The clinical ground truth is determined largely by the persistent need for inotropes past post-operative day 14 or right 
ventricular mechanical circulatory assist devices during the post-operative recovery period. MCS-ARC definitions are highlighted 
in Supplementary Table 1.  
measurements, laboratory results for renal and hepatic function, and a persistent requirement for pharmacological 
inotropic support or right ventricular mechanical circulatory support devices. Training, validation, and holdout test 
datasets were randomly created to assess performance from the remaining 723 patients (1909 scans). Multiple scans 
were available from each patient, but no patients overlapped between the training, validation, and test datasets. 
182 patients (25.13%)  were adjudicated to have post-operative RV failure.  
 
 
Echocardiography AI system and performance 
 
All current automated echocardiography systems – much like human echocardiography interpretations – are 
inherently reductionist in nature; a complex sequence and pattern of cardiac contraction is reduced to an outline of 
one or more chambers, from which a few global metrics of heart function are then calculated.25–27 Quantifying subtle 
motion characteristics of the heart that predict future risk of disease requires a shift in approach to ML in 
echocardiography. We compared the predictive performance of our AI system against two popular clinical RV failure 
risk scores used for predicting post-operative RV failure – the CRITT score and Penn score.4,6    These clinical risk 
scores combine clinical laboratory measures, hemodynamic readings, and qualitative assessments of cardiac 
function. The pre-operative variables used for calculating these scores are described in Supplementary Table 2.4,6 
The AUCs calculated for the Penn score (0.605; 95% CI 0.485-0.714) and the CRITT score (0.616; 95% CI 0.564-0.667) 
for our dataset are similar to previously published reports (Fig 2a).1,4 We evaluated the ML system at both a liberal 
operating point of 80% sensitivity, where the specificity was 52.75%, and at a more conservative operating point of 
80% specificity, where the sensitivity was 46.67%. Balancing the risks and potential benefits of interventions in this 
patient population may require different thresholds of sensitivity and specificity. Observational data suggests that 
early and aggressive therapy with right ventricular assist devices (RVADs) may improve survival in patients who are 
likely to develop post-operative RV failure.28 These decisions must be made taking into account the significant 
additional morbidity associated with biventricular mechanical circulatory assist.21,22,29 Right ventricular assist devices 
potentially could thus be offered based on cutoffs from the conservative operating point of our ML system. An 
increasing proportion of patients implanted with LVADs today are listed as ‘destination therapy’ candidates, where 
the expectation is that the LVAD will provide lifelong circulatory support.22 A heart transplant on the other hand may 
be offered after the initial LVAD implant as a ‘bridge to transplant’ strategy, with priority for receiving an organ 
guided by prevailing UNOS (United Network for Organ Sharing) allocation policies. Anecdotally 50% of all surviving 
LVAD patients at 5-years are bridged to a heart transplant in our current dataset. Though not all LVAD patients are 
suitable candidates for a heart transplant, a more liberal threshold for the ML system may be used to inform listing 
Fig. 2 Performance of the AI system, clinical risk scores, and clinical benchmarking. a. ROC curve of the ML system compared to 
contemporary clinical risk scores. b. ROC curves of clinical expert team and independently calculated metrics of right ventricular 






































strategy for heart transplantation owing to the poor short and long-term survival of LVAD patients who go on to 
develop post-operative RV failure. 
 
Clinical benchmark with human experts 
 
We benchmarked the performance of our AI system against a clinical heart failure echocardiography team. In clinical 
practice, echocardiographic assessment is used as an important adjunct metric to gauge the likelihood of 
downstream RV failure. While decisions are rarely based on echocardiography alone, a combination of poor clinical 
presentation and ‘severely depressed’ pre-operative RV function may be predictive of post-operative disease.30 A 
blinded clinical benchmark has to our knowledge, not been conducted for this clinical problem. The team of board-
certified cardiologists and a sonographer with 12 years of clinical sonography experience were blinded patient 
outcomes, and graded scans independently from the remainder of the research team. A web-based annotation tool 
(MD.ai, New York, NY) was used to take echocardiographic measures of right ventricular function.31  In addition to 
quantitative metrics, the clinical team also identified  the patients they predicted would go on to develop RV failure 
after the operation. These measures were calculated for all 121 patients in the testing dataset (n = 91 controls; n = 
30 cases with RV failure) and an additional subset of 86 (n = 70 control; n = 16 cases) randomly selected patients 
from the validation set. The AUCs of the manually extracted metrics ranged between 0.525 – 0.571. The AI system 
(n = 121; test set results only) outperformed both clinical readers and all quantitative echocardiographic metrics. 
The best performing manual echo metric (RV longitudinal strain) had an AUC of 0.5623 (95% CI 0.464-0.660; ΔAUC 
for AI system 0.167 (95% CI 0.159-0.175, p = 0.025) (Fig 2b). The AUC of the clinical team predictions was AUC of 
0.579 (95% CI 0.4971-0.643); ΔAUC for AI system 0.159 (95% CI 0.126-0.192), p = 0.016). The clinical reader team 
had a specificity of 37.89% and a sensitivity of 76.09%; for the same sensitivity, the specificity of the AI system was 
54.95%.  
 
Saliency Maps and Visualizations 
 
Interpretability of clinical AI systems has implications in 
identifying failure modes as well as in establishing trust and 
confidence in end-users.32,33 In this paper we utilized 
gradient backpropagation to generate saliency maps.34 
These are computed based on the imputed gradient of the 
target output with respect to input, where only non-
negative gradients are backpropagated; in non-technical 
terms, the goal of this technique is to find input data that 
would exemplify the features the network uses to predict 
RV Failure (or lack thereof). We show that for each patient, 
regions of activation were localized exclusively to the 
myocardium and valves. The cardiac chambers (ventricles 
and atria) themselves showed no activation. Furthermore, 
motion characteristics of specific regions of the heart 
contribute towards the prediction of RV failure at different 
phases of the cardiac cycle (Fig 3). In patients where the AI 
system correctly predicted RV failure, saliency maps 
localized over the interventricular septum, right atrium, and 






In this study we demonstrate a novel machine learning system capable of characterizing subtle myocardial motion 
aberrations on echocardiography for downstream clinical analyses. We utilize this system to predict the outcome of 











Video Input Systole Diastole
Fig. 3: Saliency maps for pre-operative 
echocardiograms. Representative input videos and 
visualizations for both systolic and diastolic phases of the 
cardiac cycle across patients with and without RV failure. 
echocardiography system outperforms board certified clinicians equipped with both manually extracted 
echocardiographic metrics and state of the art clinical risk scores. Our algorithm predicts a binary outcome of RV 
failure, though our methods can readily be extended to predict continuous and multi-class outcomes of interest.  
 
The poor predictive performance of contemporary clinical risk scores is well documented. Many of the input 
variables are consequences rather than true predictors of RV failure. Most risk scores were developed without 
internal cross-validation or falter when evaluated on held-out datasets.1,5,8,35 More recently, some investigators have 
attempted to use Bayesian networks on pre-operative parameters sourced from the INTERMACS registry to predict 
post-operative RV failure.36 Critically, pervasive issues with missing data and severe class imbalance in these 
registries (2.7% RV failure, vs 97.3% normal patients) may have biased the results with overestimations of predictive 
power, especially when using performance metrics sensitive to changes in class imbalance.37 We have employed the 
latest standardized definitions of post-operative RV failure.24 In the past, definitions of post-operative RV failure 
were largely based on the need to implant a right ventricular assist device – an intervention driven by surgeon 
preference and institution specific nuance. The current definitions allow for standardized and generalizable ground 
truth labels for post-operative RV failure across all participating institutions. By abstaining from defining ‘mild’ and 
‘moderate’ RV failure (as only more ‘severe’ grades were found to impact long term outcomes), the current MCS-
ARC guidelines offer a more clinically relevant target for our ML system.35,3  
 
All contemporary echocardiography  ML systems rely on supervised segmentation algorithms to outline cardiac 
chambers.25,38 Most recently, Ouyang et al described a weakly supervised video segmentation system to calculate 
ejection fraction using left ventricular tracings in conjunction with spatiotemporal convolutions.26  Our methods offer 
a number of key improvements: First, instead of segmenting cardiac chambers, our AI system directly analyses 
spatiotemporal information from the cardiac musculature and valves by default - the principal regions of interest in 
all cardiac diseases. This enables the algorithm to characterize subtle, regional aberrations in myocardial motion, 
that traditional manually extracted echocardiographic measures fail to capture. Secondly, our end-to-end system 
tracks features of importance without human supervision in the form of segmentation masks. This method is not 
dependent on cardiac view plane or chamber, enabling rapid deployment of our methods to a diverse array of 
echocardiography problems. Finally, we use two streams of spatiotemporal information in the form of greyscale 
video channels and optical flow to directly predict downstream outcomes of interest. Combined two-stream 
networks achieve state-of-the-art performance on large video recognition datasets.39 Our system makes inferences 
on a single study within 500ms on a single Nvidia GeForce RTX 2080Ti GPU. An additional computational overhead 
of 10s however is needed for calculating optical flow per input video. In the context of our clinical problem, the 
additional computational overhead of calculating optical flow is acceptable. Future work may focus on integrating 
faster deep learning methods of optical flow estimation within the AI pipeline for applications that require real time 
inference.40  
 
Analyzing echocardiography videos rather than clinical or laboratory metrics allows for a direct visual assessment of 
cardiac function. The literature surrounding the predictive value of manually calculated metrics of cardiac function, 
however, remains inconclusive.41,42 Our echocardiography ML system outperforms manually calculated metrics of 
myocardial function in predicting RV failure. Automating the calculations of these hand-measured metrics using 
image segmentation algorithms are therefore unlikely to be predictive of our outcome of interest, further supporting 
our rationale for transitioning to an end-to-end architecture.  While our AI system was trained using the largest 
echocardiographic heart failure dataset of its kind, there remain several limitations of our work. The retrospective 
nature of our dataset and the lack of a standardized echocardiography acquisition protocol limits the quality and 
timing of the scans prior to the index operation. Most scans were taken 9 days prior to LVAD surgery, though this 
window was larger for some patients. Furthermore, a comprehensive assessment of right ventricular function 
remains challenging without additional echocardiographic views (subcostal views, parasternal long axis).43 It is 
plausible that superior predictive systems can be trained using prospectively collected echocardiographic data. Key 
to such efforts are standardized and comprehensive protocols for acquisition of scans at pre-defined timepoints 
before index surgery. Prospective evaluation in the clinical setting will be essential to understand the limitations of 
our technology. Finally, unlike hard radiological or histopathological ground truth labels, the clinical ground truth for 
post-operative RV failure leaves room for subjectivity despite the MCS-ARC guidelines.   
 
Our methods are, to our knowledge, the first to predict the onset of disease using video-based echocardiography 
ML.  Our system may serve as a clinical decision support system beyond instituting effective RV rescue treatments 
for this patient population; including the early detection of left heart failure, disease phenotyping, and a multitude 
of cardiac clinical decision support applications where treatment or patient selection is guided by qualitative 





Data sources and study population: 
Data in the form of clinical outcomes and raw echocardiography DICOM files were sourced from the departments of 
Cardiothoracic Surgery at Stanford University (CA), Spectrum Health (MI), and the Houston Methodist Hospital (TX); 
(IRB 52440). All patients aged 18-years or older with at least one pre-operative transthoracic echocardiogram as well 
as a complete pre-operative and post-operative assessment of RV failure during index-hospitalization as per the 
MCS-ARC consensus definitions (Mechanical circulatory assist academic research consortium) were included 
(Supplementary Table 1).24 Apical 4 chamber views for trans-thoracic echocardiograms taken closest to the day of 
surgery were used for this study. Our final dataset comprised 723 patients. Raw data was anonymized and linked to 
clinical outcomes data via a unique study-ID. As the MCS-ARC definitions were standardized in August 2020, we 
manually reviewed each patient record for the duration of inpatient admission to collect pre-operative and post-
operative clinical parameters following a pre-determined and standardized protocol.24 This enabled accurate grading 
of RV failure severity along with the calculations of the various RV failure risk scores. The research team tasked with 
developing and training the artificial intelligence system did not have access to the original patient charts. Clinical 
data was stored and managed in REDCap.44 
 
Outcomes: 
The primary outcome of the study was the ability of the AI system to identify and predict the likelihood of post-
operative RV failure using only pre-operative transthoracic echocardiograms as the input.  All patients with MCS-
ARC defined post-operative RV failure were included in the ‘RV failure’ group (n = 182 patients; 25.13%); the 




Echocardiograms were first de-identified by stripping all private health information (PHI) from file metadata and by 
obscuring any sensitive information in the videos. The complete removal of all sensitive information was verified 
manually on all videos before proceeding to downstream postprocessing. Areas outside of the scanning sector were 
masked to remove any miscellaneous markings in the video frames that may otherwise influence the neural 
networks. The videos were then normalized by dividing each pixel value by the pixel of maximal intensity. The frames 
of the processed videos were additionally down-sampled by bi-linear interpolation to a 112x112 resolution for 
training and evaluation. Optical flow was calculated prior to model training using an OpenCV implementation of the 
Gunnar Farnebäck method based on polynomial expansion.45 Additional data augmentation operations such as 
random 3-dimensional shearing, scaling, rotation, brightness multiplication were utilized as part of the training loop.  
 
Neural Network Architecture and Training: 
We use a 3-dimensional convolutional neural network,46 built using the Keras Framework with a TensorFlow 2.0 
(Google; Mountain View, CA, USA) backend and Python, that tracks motion features and structural features in blocks 
of 32 consecutive frames. We make use of bottlenecked residual blocks expanded to 3-dimensions. We used 
validation data to do model selection over a range of architectures and tested multiple 3D neural network 
architectures before selecting a two-stream fusion 152-layer 3D Residual Network with bottlenecks incorporated 
within the residual blocks (Supplementary Fig. 2).47,48 The residual blocks utilize a convolutional layer with a 3 x 3 x 
3 kernel, sandwiched between two 1 x 1 x 1 convolutional layers. The first convolutional layer utilizes a 7 x 7 x 7 
kernel.48 The network weights were initialized using the Xavier normal initializing scheme, and was optimized using 
the AdamW algorithm.49,50 The network was trained for 50 epochs on a batch size of 8, with an initial learning rate 
of 1x10-5. Training was stopped early if the training loss did not improve for 5 epochs. For each echocardiogram, 5 
random 32-frame clips of the full movie were subsampled and passed through the trained neural network. The 
average of the 5 outputs was calculated to predict RV failure. Hyperparameter tuning was carried out on the 
validation dataset. We implemented a proportional loss weighting strategy during training with a binary cross-
entropy loss function, to account for the effect of minor class imbalance. The binary cross-entropy loss function is 
given by the following equation: 
 






All candidate networks were pre-trained on the Kinetics-600 dataset for video action recognition.51 Videos in the 
Kinetics-600 dataset were converted to greyscale and optical flow and subsampled for 32 consecutive frames prior 
to pre-training. Pre-training on Kinetics600 was performed on servers, each with eight NVIDIA V100 GPUs, on the 
Stanford Sherlock Supercomputing Cluster. The Kinetics600 initialized networks were then trained on the Stanford 
AI in Medicine Center echocardiography dataset for Ejection Fraction prediction with over 10,000 Apical 4-Chamber 
echocardiography videos.26 Training was stopped when validation loss did not improve, and the model weights were 
saved. The networks for RV failure prediction were finally initialized with these weights and the terminal linear 
activation function was replaced by a sigmoid function. In our experiments we find that pretraining significantly 
improves training convergence, with higher validation AUC and lower cross-entropy losses. This corroborates 
findings from a number of groups working on both medical imaging and general purpose video action recognition 
problems.11,26,39  
 
Visualizations and interpretations 
We used an implementation of Gradient backpropagation to generate saliency maps for the AI system as it makes 
predictions of RV failure outcome when passed through the 3-dimensional convolutional neural network.32,34  
Visualization of representation learned by higher layers of the network are generated by propagating the output 
activation back through the ReLU function in each layer 3 and setting the negative gradients to zero: 
 
4!(') = (5!' > 0) ∙ (4!')% > 0) ∙ 4!')% 
 
Alternative visualization techniques such as layer wise relevance propagation were also considered. The neurons 
that contribute the most to the higher layers receive the most ‘relevance’ from it. The relative contribution of each 
pixel towards the final predicted value is quantified to satisfy the following equation:  
 
4!←+(',')%) = 4+(')%) -!.!"∑ -#.#"#  
 
The total relevance 4 is conserved between layers 3. During each forward pass, neuron 9 inputs  :!;!+ to the next 
connected neuron <. The messages 4!←+(',')%) distribute the relevance 4+(')%) of a neuron < , onto the preceding 
neurons that feed into it at layer 3. The presence of skip connections in 3D residual networks violates the assumptions 
of relevance conservation, limiting us to Gradient backpropagation.  
 
 
AI performance and comparison with clinical risk scores: 
The US dataset was split in an approximate 66:17:17 ratio into a training, validation, and test dataset. The stratified 
split ensured proportional numbers of unique patients with and without RV failure in each group. The validation set 
was used for hyperparameter tuning and an ensemble of 3 models trained with identical settings were used to 
generate final predictions at the scan level.  On freezing the model weights, model performance was evaluated on 
the testing dataset using the area under curve (AUC) of the receiver-operator characteristic and AUC of the precision-
recall curve.  We further compared the predictive performance of our AI system against clinicians equipped with two 
contemporary risk scores used in for predicting post-operative RV failure - the CRITT score and Penn score. The 
variables used for calculating these scores are described in Supplementary Table 2.4,6  Missing data prevented the 
calculation of clinical risk scores for as many as 37% of all patients in our total dataset. For this reason, we elected 
to use a multiple imputation strategy following Rubin’s rules to pool and calculate AUCs.52,53 No significant difference 
in AUC was noted in the original incomplete dataset vs the imputed dataset (1% lower in imputed Penn Score; 0.2 % 
higher in imputed CRITT Score). Imputation diagnostic plots are shown in Supplementary Fig 5. 
 
 
Comparisons with manually calculated echocardiography metrics 
We compared the performance of AI based RV failure prediction to a set of manually derived echocardiographic 
measures of right ventricular function. These measures were independently calculated by two board certified 
cardiologists for 207 patients (n = 161 controls; n = 46 with RV failure) in our dataset, using metrics of RV function 
previously described.31 The echocardiography scans were hosted on a secure Google Cloud Bucket at full resolution, 
ranging from a resolution of (422 x 636) to (768 x 1024) pixels. A custom cloud-based annotation system (MD.ai, 
New York) was used to allow the clinical heart failure team to remotely take measurements, perform quality control, 
and adjudicate metrics of RV failure (Supplementary Fig. 1). The scans were uploaded in a random order and no time 
constraints were provided to the clinical team. The clinical team-based adjudication approach mimics the clinical 
setting, where clinical sonographers and board-certified cardiologists together assess patients with end-stage heart 




No statistical methods were used to predetermine sample size. To evaluate the stand-alone performance of the AI 
system, ROC curves were calculated as empirical curves in the sensitivity and specificity space. AUCs for ROC curves 
were computed with trapezoids using the pROC package.54 AUC for the Precision-Recall curve was computed using 
the interpolation method described by Davis and Goadrich.55 To compare the performance of our AI system against 
clinical risk scores and manually calculated echo metrics, we calculated non-parametric confidence intervals on the 
AUC using DeLong’s method,56 following which p-values were computed for the mean difference between AUC 
curves. Missing data for clinical risk scores were addressed with multiple imputation with chained equations using a 
univariate imputation method (predictive mean matching).57 The pooled AUC for the imputed datasets (n = 20; max 
iterations = 50) was calculated using Rubin’s Rules by log transforming the AUC prior to pooling.52 Statistical analyses 
were conducted in R (v3.6.2). 
 
 
Data Availability  
 
The dataset for this study was acquired under data transfer agreements that restrict public release due to the 
potential embedded protected health information present in the raw data.  
 
Code Availability  
 
TensorFlow codebase including our models, training and evaluation scripts, and accessory R scripts for the final 
analyses and plots are available on GitHub (Release pending peer review). Supplement will be made available 
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